Where is the completed adverse reaction report form submitted?

Submission pathways depend on national regulatory requirements and local health authority guidelines governing pharmacovigilance reporting.

Must all adverse effects of new drugs be reported?

Yes, if a new drug is in the clinical trial phase, absolutely all identified adverse effects must be reported, regardless of their severity.

What document must a pharmacist complete in the event of a serious reaction?

The pharmacist is required to document the case by completing the standardized Adverse Drug Reaction Report Form.

Is it necessary to notify the physician in case of a life-threatening adverse effect?

Yes, the algorithm obligates the pharmacist to notify both pharmacy management and the patient's attending physician upon identifying serious conditions.

What should be done if the adverse effect is non-serious and described in the labeling?

In standard cases (non-serious and known reactions), it is sufficient for the pharmacist to recommend that the patient consult their attending physician.

Home › Pharmacology › Pharmacist Action Algorithm for Adverse Drug Reactions

Pharmacist Action Algorithm in Case of Adverse Drug Reactions

For medical students2 min readUpdated 2026-10-10

The pharmacist's action algorithm for identifying adverse drug reactions (ADRs) is a critical component of the pharmacovigilance system. It strictly defines the professional responsibility: from providing emergency first aid and completing report forms to routing the patient to their attending physician depending on the severity of the reaction.

Life ThreatLife-threatening reactions require mandatory and immediate reporting by the healthcare professional.

DocumentationA standardized ADR reporting form must be completed to document severe reactions.

New DrugsAny adverse effects of investigational drugs in clinical trials must be recorded.

Mild ADRsFor known and non-serious reactions, the patient should be directed to consult their attending physician.

Criteria for Serious Conditions Requiring Mandatory Reporting

As part of pharmacovigilance, the pharmacist bears professional responsibility for monitoring pharmacotherapy safety. There is a clear set of criteria that classify an adverse effect as serious, requiring mandatory official reporting.

Conditions subject to strict recording include:

Life threat: Any adverse effect that poses an immediate danger to the patient's life at the time of onset.
Unexpected reactions: The development of undesirable effects that have not been previously studied and are not described in the official product labeling (package insert).
Severe consequences: Adverse reactions whose severity leads to temporary disability or requires emergency or elective hospitalization.
Investigational drugs: The occurrence of absolutely any, even minor, adverse effect when taking a new drug if it is currently undergoing clinical trials.

Pharmacist Responsibilities in Identifying Serious Reactions

If a patient's condition meets the criteria for a serious event (life-threatening, unexpected, resulting in hospitalization, or related to clinical trials), the pharmacist's action algorithm is strictly regulated. The specialist must perform the following steps:

Provide emergency pre-medical care. The primary task of the pharmacist is to stabilize the patient's condition in the event of an acute or life-threatening reaction directly within the pharmacy setting.
Document the case. After providing assistance, the incident must be officially recorded. To do this, the pharmacist must complete the standardized ADR Report Form.
Notify responsible parties. Information regarding a severe or unusual adverse effect must be promptly transmitted to pharmacy management and the patient's attending physician who prescribed the medication.

Management of Non-Serious and Known Adverse Effects

Not every adverse event requires emergency measures, completion of report forms, or management notification.

If the developed adverse effect is considered non-serious, and its manifestations are already described in the package insert, the action algorithm is significantly simplified. In such situations, it is sufficient for the pharmacist to provide appropriate counseling and strongly recommend that the patient consult their attending physician. The physician will then assess the condition and, if necessary, adjust the pharmacotherapy regimen or dosage.

Mnemonic

The "PAD" rule for serious adverse effects: Provide aid (first aid), Alert (management and physician), Document (complete the report form).

Frequently asked questions

Where is the completed adverse reaction report form submitted?: Submission pathways depend on national regulatory requirements and local health authority guidelines governing pharmacovigilance reporting.
Must all adverse effects of new drugs be reported?: Yes, if a new drug is in the clinical trial phase, absolutely all identified adverse effects must be reported, regardless of their severity.
What document must a pharmacist complete in the event of a serious reaction?: The pharmacist is required to document the case by completing the standardized Adverse Drug Reaction Report Form.
Is it necessary to notify the physician in case of a life-threatening adverse effect?: Yes, the algorithm obligates the pharmacist to notify both pharmacy management and the patient's attending physician upon identifying serious conditions.
What should be done if the adverse effect is non-serious and described in the labeling?: In standard cases (non-serious and known reactions), it is sufficient for the pharmacist to recommend that the patient consult their attending physician.

Go deeper

Organization of national pharmacovigilance systems
First aid protocols in pharmacy practice
Standard operating procedures for adverse event reporting
Distinction between clinical trials and post-marketing surveillance